BRIEF published on 05/24/2024 at 17:50, 1 year 6 months ago CIBOX General Meeting of June 27, 2024 Shareholders Paris 2024 General Assembly CIBOX
BRIEF published on 04/26/2024 at 17:50, 1 year 7 months ago 2024 financial agenda for CIBOX in the field of electric micro-mobility Financial Results Euronext Paris CIBOX Electric Micro-mobility Financial Diary
BRIEF published on 04/24/2024 at 19:50, 1 year 7 months ago CIBOX Year 2023 Results: A Transition Towards New Opportunities Financial Results 2023 Growth 2024 CIBOX Electric Micro-mobility Industrial Transition
BRIEF published on 04/23/2024 at 18:00, 1 year 7 months ago Change in capital and voting rights of CIBOX as of March 31, 2024 Share Capital Voting Rights Actions Euronext Growth CIBOX
BRIEF published on 04/17/2024 at 18:25, 1 year 7 months ago CIBOX Performance and Projects in the First Quarter of 2024 Growth International Sales CIBOX Electric Micro-mobility Delayed Production
Published on 12/05/2025 at 02:35, 3 hours 50 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 25 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 20 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 25 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 55 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 34 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 10 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 14 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 25 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 40 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 41 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 24 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
